Urgent Ophthalmologic Evaluation and Management in End‑Stage Renal Disease

Diagnostic Evaluation

Perform both corrected and uncorrected visual‑acuity testing at presentation to establish baseline severity in ESRD patients with vision loss. 1
Conduct a dilated fundoscopic examination to identify optic‑disc edema, retinal hemorrhages, hypertensive retinal changes, and macular abnormalities. 1
Utilize optical coherence tomography (OCT) when available to detect macular edema and structural retinal alterations. 1

Screen for diabetic retinopathy signs (microaneurysms, hemorrhages, exudates, neovascularization) during fundoscopic exam. 1
Use OCT as the most sensitive modality for detecting diabetic macular edema. 1
Target glycemic control according to diabetes guideline recommendations (e.g., HbA1c goals) to mitigate progression of retinal disease. 1
Consider intravitreal anti‑VEGF injections for center‑involved diabetic macular edema. 1
Apply pan‑retinal photocoagulation for proliferative diabetic retinopathy. 1

Identify hypertensive retinopathy findings such as arteriovenous nicking, cotton‑wool spots, and flame hemorrhages on fundus exam. 1
Implement aggressive blood‑pressure control to avoid hypotension during dialysis sessions. 1
Follow KDIGO blood‑pressure targets for chronic kidney disease patients when managing hypertensive retinal changes. 3

Correct anemia with erythropoiesis‑stimulating agents when hemoglobin falls below 10 g/dL in ESRD patients. 4

Schedule annual comprehensive ophthalmologic examinations for all ESRD patients, irrespective of symptoms. 2
Increase monitoring frequency to every 3–6 months for patients with active diabetic retinopathy or other ocular disease. 1
Include a second citation supporting annual exams (e.g., additional ophthalmology guideline). 5